KRAS and cancer: Genomic markers (MSI and BRAFV600E) and tumor microenvironment markers (cancer-associated fibroblasts and cytotoxic lymphocytes) showed similar subtype associations in the cCMS and original CMS frameworks, with the exception that KRAS mutations were not skewed among cCMS classes (Supplementary Data 10).